optive.de Report : Visit Site

Technical data of the optive.de

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host optive.de. Currently, hosted in United States and its service provider is Amazon Technologies Inc. .

the related websites

optive.co.uk walgreens.com netdoctor.co.uk allergan.co.uk eyeresearch.co.uk neneccg.nhs.uk visiondirect.com butterflies-eyecare.co.uk 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/10.0 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

home < home investors < investors news < news investor faqs < investor faqs analysts coverage < analysts coverage stock information < stock information m&a; activities < m&a; activities corporate governance < corporate governance shareholder services < shareholder services financial information < financial information products < products what we treat < what we treat key products < key products drug safety < drug safety quality < quality patent notices < patent notices medical information < medical information r & d < r & d we live open science < we live open science r&d; areas of focus < r&d; areas of focus clinical trials < clinical trials pre-approval access < pre-approval access about < about company profile < company profile executive leadership < executive leadership global footprint < global footprint global locations < global locations contact < contact news < news press releases < press releases media contacts < media contacts newsroom < newsroom careers < careers career opportunities < career opportunities working at allergan < working at allergan our employees < our employees fellowship program < fellowship program responsibility < responsibility social contract < social contract social responsibility < social responsibility allergan foundation < allergan foundation california supply chain disclosure < california supply chain disclosure alliance support and ime grants < alliance support and ime grants health care provider partnerships & payments < health care provider partnerships & payments patient resources < patient resources patient safety & product quality < patient safety & product quality physician resources < physician resources animal testing < animal testing home investors products r & d about news careers responsibility search home > investors > read the full story> allergan acquisition: investor information news events & presentations investor faqs analysts coverage stock information stock chart & quote historical price lookup investment calculator preferred shares m&a; activities allergan acquisition forest laboratories acquisition warner chilcott acquisition teva agreement corporate governance executive officers and directors committee composition committee charters code of conduct governance guidelines insider transactions allergan compliance program memorandum of association shareholder services information requests investor kit e-mail alerts dividends financial information sec filings annual reports quarterly results proxy materials products > what we treat key products our products product prescribing drug safety quality patent notices medical information medical information request r & d > we live open science r&d; areas of focus advancing the pipeline clinical trials participating in an allergan clinical trial clinical trial results sharing post marketing commitments sharing patient-level data clinical trials investigators investigator initiated trials pre-approval access about > company profile executive leadership global footprint pharmaceuticals business development global locations commercial operations supply chain countries contact news > ceo blog press releases media contacts newsroom allergan images allergan logos company profile executive bios & photos careers > career opportunities working at allergan our employees star seyedkazemi albert yao caitlin sandahl jose miguel herrera shuyan li christine birchnall fellowship program responsibility > social contract social responsibility community sustainability environmental employees partners public policy allergan foundation california supply chain disclosure alliance support and ime grants alliance support independent medical education grants health care provider partnerships & payments affordable care act patient resources patient assistance programs patient safety & product quality research and development risks and benefits quality physician resources animal testing >go! our employees i am bold for life: star seyedkazemi read more news 11.26.2018 | investors allergan makes new appointments to finance leadership team 11.20.2018 | investors allergan to present at the 2018 citi global healthcare ... see all news > q3 2018 earnings pdfs for download q3 2018 earnings release > q3 2018 earnings presentation > q3 2018 earnings infographic > stock quote refresh quote exchange volume country websites global corporate website africa egypt south africa americas argentina barbados bolivia brazil canada chile colombia costa rica dominican republic ecuador el salvador guatemala honduras jamaica mexico panama peru puerto rico trinidad & tobago uruguay venezuela asia pacific australia bahrain bangladesh china hong kong india indonesia isreal japan jordan korea kuwait lebanon malaysia new zealand pakistan palestine philippines saudi arabia singapore sri lanka taiwan thailand united arab emirates vietnam europe austria belgium bulgaria czech republic denmark estonia finland france germany greece hungary ireland italy latvia lithuania malta netherlands norway poland portugal romania russia serbia slovakia spain sweden switzerland turkey ukraine united kingdom global compliance terms privacy sitemap © allergan 2018 by selecting " i accept ," i authorize allergan, or any contracted third parties acting on its behalf, to install cookies on my browser to remember the information that i input, track how i use sections of websites, enable allergan to remember my user custom preferences, and to tailor my access to the website per my preferences. allergan’s websites may ask your browser to store cookies, a small piece of data, on your computer or mobile device. a cookie can be used to enable a site to remember information that you previously input. it also helps deliver content-specific information to you and tracks how sections of websites are used. we may also use cookies to understand your preferences and tailor your access to your preferences. your consent is required for allergan to remember your user details and preferences over time. if you consent, choose “i accept.” you can withdraw your consent by changing your browser settings to erase cookies from your computer’s hard drive, block all cookies, or receive a warning before a cookie is stored. please check your internet browser’s instructions to learn more about these functions. your consent is voluntary; however, if you do not consent to cookies being installed on your browser, allergan may not be able to provide you full access to or all the functionality of our websites. read more

URL analysis for optive.de

http://www.allergan.com/about/global-locations/countries/ukraine
https://www.allergan.com/home/responsibility/alliance-support-and-ime-grants/independent-medical-education-grants
https://www.allergan.com/home/products/drug-safety
http://www.allergan.com/about/global-locations/countries/malaysia
http://www.allergan.com/about/global-locations/countries/turkey
https://www.allergan.com/home/news/news/thomson-reuters/allergan-makes-new-appointments-to-finance-leaders
https://www.allergan.com/home/investors/corporate-governance/insider-transactions
https://www.allergan.com/home/investors/m-a-activities
https://www.allergan.com/home/careers/career-opportunities
https://www.allergan.com/home/products
https://www.allergan.com/home/responsibility/social-contract
https://www.allergan.com/home/about/company-profile
https://www.allergan.com/home/investors/shareholder-services/investor-kit
https://www.allergan.com/home/investors/corporate-governance/committee-charters
https://www.allergan.com/home/investors/stock-information/investment-calculator

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

% Copyright (c) 2010 by DENIC
% Version: 2.0
%
% Restricted rights.
%
% Terms and Conditions of Use
%
% The data in this record is provided by DENIC for informational purposes only.
% DENIC does not guarantee its accuracy and cannot, under any circumstances,
% be held liable in case the stored information would prove to be wrong,
% incomplete or not accurate in any sense.
%
% All the domain data that is visible in the whois service is protected by law.
% It is not permitted to use it for any purpose other than technical or
% administrative requirements associated with the operation of the Internet.
% It is explicitly forbidden to extract, copy and/or use or re-utilise in any
% form and by any means (electronically or not) the whole or a quantitatively
% or qualitatively substantial part of the contents of the whois database
% without prior and explicit written permission by DENIC.
% It is prohibited, in particular, to use it for transmission of unsolicited
% and/or commercial and/or advertising by phone, fax, e-mail or for any similar
% purposes.
%
% By maintaining the connection you assure that you have a legitimate interest
% in the data and that you will only use it for the stated purposes. You are
% aware that DENIC maintains the right to initiate legal proceedings against
% you in the event of any breach of this assurance and to bar you from using
% its whois service.
%
% The DENIC whois service on port 43 never discloses any information concerning
% the domain holder/administrative contact. Information concerning the domain
% holder/administrative contact can be obtained through use of our web-based
% whois service available at the DENIC website:
% http://www.denic.de/en/domains/whois-service/web-whois.html
%

Domain: optive.de
Nserver: ha1.markmonitor.zone
Nserver: ha2.markmonitor.zone
Nserver: ha3.markmonitor.zone
Nserver: ha4.markmonitor.zone
Status: connect
Changed: 2017-07-10T20:44:21+02:00

[Tech-C]
Type: PERSON
Name: Domain Administrator
Organisation: Allergan, Inc.
Address: 2525 Dupont Drive
PostalCode: 92612
City: Irvine
CountryCode: US
Phone: +1.7142466799
Fax: +1.7142462418
Email: [email protected]
Changed: 2011-04-06T01:27:19+02:00

[Zone-C]
Type: PERSON
Name: Domain Admin
Organisation: MarkMonitor Inc
Address: 3540 East Longwing Lane
Address: Suite 300
PostalCode: 83646
City: Meridian
CountryCode: US
Phone: +1.2083895740
Fax: +1.2083895771
Email: [email protected]
Changed: 2017-06-05T17:55:26+02:00

  REGISTRAR DENIC eG

  REFERRER http://www.denic.de/

SERVERS

  SERVER de.whois-servers.net

  ARGS -T dn,ace optive.de

  PORT 43

  TYPE domain

DOMAIN

  NAME optive.de

NSERVER

  HA1.MARKMONITOR.ZONE 208.78.70.138

  HA2.MARKMONITOR.ZONE 204.13.250.138

  HA3.MARKMONITOR.ZONE 208.78.71.138

  HA4.MARKMONITOR.ZONE 204.13.251.138

  STATUS connect

  CHANGED 2011-04-06

TECH

  NAME Domain Administrator

  ORGANIZATION Allergan, Inc.

ADDRESS

STREET
2525 Dupont Drive

  PCODE 92612

  CITY Irvine

  COUNTRY US

  PHONE +1.7142466799

  FAX +1.7142462418

  EMAIL [email protected]

ZONE

  NAME Domain Admin

  ORGANIZATION MarkMonitor Inc

ADDRESS

STREET
3540 East Longwing Lane
Suite 300

  PCODE 83646

  CITY Meridian

  COUNTRY US

  PHONE +1.2083895740

  FAX +1.2083895771

  EMAIL [email protected]

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .